Phil McAtee in

Phil McAtee

Director of Business Development and National Accounts at PharmaLink, Inc.
📍 Indianapolis, Indiana, United States

Professional overview including current role context, leadership scope, domain focus, and career trajectory to help you understand background relevance before outreach.

Key behavioral and communication insights including interaction style, decision-making tendencies, and motivation drivers to tailor messaging and personalize conversations.

Business priorities, areas of interest, and practical outreach recommendations that can improve conversion quality for this professional.

Login to view overview
Experience
24 Years
Current Role
Director of Business Development and National Accounts
Job Level
Mid-senior
Location
Indianapolis, Indiana, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities

Topics Phil cares about

Strategic Priorities
Topic insights and context to help personalize outreach and discovery conversations.
Login to view topics
Career

Work history

11-2025
Director of Business Development and National Accounts
PharmaLink, Inc.
7-2025 - 11-2025
Director of National Programs
Clean Earth
5-2025 - 7-2025
Environmental Professional
Self-employed
1-2020 - 3-2025
Vice President, Sales and Marketing
Heritage Environmental Services
1-2009 - 1-2020
Corporate Accounts & Healthcare Services
Heritage Environmental Services
In the press

Media appearances

Media appearances and press coverage highlighting public visibility and thought leadership.
Login to view
Education
1990 - 1994
BS
Purdue University
2008 - 2008
Mendoza College of Business Education
University of Notre Dame
Social presence
in

Other PharmaLink, Inc. Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Phil. Free, 10 seconds.